Occludin anticorps (C-Term)
Aperçu rapide pour Occludin anticorps (C-Term) (ABIN337048)
Antigène
Voir toutes Occludin (OCLN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Marque
- IHC-plus™
-
Specificité
- Recognizes mammalian Occludin Protein. Species cross-reactivity: human, mouse, rat and canine.
-
Purification
- Protein A purified
-
Immunogène
-
GST fusion protein consisting of the C-terminal region (~150aa) of human occludin.
Type of Immunogen: Fusion protein -
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
-
Approved: ELISA (0.1 - 1 μg/mL), IF (2 - 3 μg/mL), IHC, IHC-P (10 μg/mL), WB (0.1 - 1 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 10 μg/mL. Positive control: T84 cell line (human intestinal epithelium), MDCK cells (canine kidney), rat liver and Caco-2 cells (human colon adenocarcinoma). Does not appear to detect the most highly phosphorylated form of the occludin protein when tested on Caco-2 cells. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
-
: "Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions." dans: PLoS ONE, Vol. 8, Issue 2, pp. e56419, (2013) (PubMed).
-
: "Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions." dans: PLoS ONE, Vol. 8, Issue 2, pp. e56419, (2013) (PubMed).
-
- Occludin (OCLN)
-
Autre désignation
- OCLN / Occludin
-
Sujet
-
Name/Gene ID: OCLN
Synonyms: OCLN, Occludin, BLCPMG -
ID gène
- 100506658
-
UniProt
- Q16625
-
Pathways
- Cell-Cell Junction Organization, Hepatitis C
Antigène
-